Penumbra (NYSE:PEN) Reports Bullish Q4 CY2025

Medical device company Penumbra (NYSE:PEN) beat Wall Street’s revenue expectations in Q4 CY2025, with sales up 22.1% year on ...
Nasdaq

Penumbra Augments Vascular Franchise with Latest Indigo System Launch and Expands Medical/Scientific Leadership

Launches Indigo® System Lightning™ 12 in U.S. Appoints Corey L. Teigen, M.D., as Chief Scientific Officer and James F. Benenati, M.D., FSIR, as Chief Medical Officer Lightning™ 12 – Intelligent ...

Boston Scientific Faces AXIOS Recall And US$11b Penumbra Deal Shift

Boston Scientific (NYSE:BSX) announced a Class I recall of its AXIOS Stent and Electrocautery-Enhanced Delivery Systems due ...
Business Wire

Penumbra Receives FDA Clearance for RED 62 Reperfusion Catheter, Enabling Physicians to Address Broad Range of Stroke Patients

Now available in the U.S., RED ™ 62 is engineered with optimized trackability to help navigate the complex distal vessel anatomy in the brain and deliver powerful aspiration for the removal of blood ...
Endovascular Today

Addressing Pelvic Venous Disease With a New Class of Coils

How do we take on and resolve vein-related pelvic pain in women? PeVD has been associated with venous-origin chronic pelvic ...
CNBC

Shares of medical device maker Penumbra tank after short seller releases critical report

Shares of Penumbra were sliding after short-seller Quintessential Capital Management released another critical report on the company. The firm first began targeting Penumbra in November. The ...